Woman's World · Mar 2026
Feature article explaining the skin-pH rationale behind Soteri Skin's approach and describing clinical results and barrier-repair framing.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Soteri Skin is a Harvard-developed, Y Combinator-backed direct-to-consumer skincare company focused on non-steroidal, pH-correcting eczema treatments that aim to restore the skin barrier and reduce flare-ups over time.
Primary product
Non-steroidal, pH-correcting OTC eczema creams and kits (pH/LOCK® eczema relief line)
Founded
2021
Headquarters
San Francisco, California, United States
Team size
1-10 employees
Industry
Personal Care Product Manufacturing
Sub-industry
Eczema skincare / medical skincare / D2C personal care
Offices
San Francisco, California, United States
Open Positions
0 jobs at SOTERI SKIN
No open positions
Check back later for new openings